Journal of Medical Screening > Volume 16, Number 3 > Pp. 147-154

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Wald, D. S Articles by Bestwick, J. P PubMed PubMed Citation Social Bookmarking                      What's this?

Original Articles

Carotid ultrasound screening for coronary heart disease: results based on a meta-analysis of 18 studies and 44,861 subjects

David S Wald, MD, MRCP, Consultant Cardiologist and Senior Lecturer  , Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK

Jonathan P Bestwick, MSc, Statistician , Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK

Correspondence to: David S Wald, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK; d.s.wald{at}qmul.ac.uk

---

Background Carotid artery ultrasound is a possible screening test for future coronary heart disease (CHD) events to select individuals for preventive treatment.

Objectives To assess the screening performance of carotid artery intima-media thickness (IMT) and carotid plaque in the identification of individuals with CHD.

Methods Meta-analysis of case-control and cohort studies, reporting carotid IMT or plaque in individuals with and without CHD. Screening performance (detection rates [DRs] for specified false-positive rates [FPRs]) was assessed from the relative Gaussian distributions of IMT among individuals with and without CHD and from the proportion of affected and unaffected individuals with plaque.

Results Eighteen studies, involving 2920 individuals with CHD (mean age range 46–73 years) and 41,941 without (aged 44–73 years) were included in the meta-analysis. For plaque the DR was 62% for an FPR of 30%; likelihood ratio (2.1 [95% CI 1.6–2.4]). For IMT, the DR was 65% for the same 30% FPR (IMT cut-off 0.82 mm); likelihood ratio 2.2 (1.9–2.5). The results were similar in case-control and cohort studies.

Conclusion Neither carotid plaque nor IMT has a CHD screening performance that is sufficiently discriminatory between affected and unaffected individuals to be a worthwhile screening test.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. S Wald, J. P Bestwick, G. Morton, L. Drummond, N. Jenkins, P. Khodabakhsh, and N. P Curzen Combining carotid intima-media thickness with carotid plaque on screening for coronary heart disease J Med Screen, September 1, 2009; 16(3): 155 - 159. [Abstract] [Full Text] [PDF]